Evidence map›Paper›PMID 32477260›Full record

ArticleFrontiers in endocrinology2020

Allopregnanolone, the Neuromodulator Turned Therapeutic Agent: Thank You, Next?

Graziano Pinna

Erratum issuedAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Neurosteroid influence on affective tone.Neuroscience and biobehavioral reviews · 2023
    Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Allopregnanolone in Postpartum Depression.Frontiers in global women's health · 2022
    Review
  19. Experience-Regulated Neuronal Signaling in Maternal Behavior.Frontiers in molecular neuroscience · 2022
    Review
  20. Inhibition of human macrophage activationFrontiers in immunology · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Graziano PinnaDepartment of Psychiatry, The Psychiatric Institute, University of Illinois at Chicago, Chicago, IL, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnestheticsHumansMood DisordersNeurotransmitter AgentsPregnanolonePrognosisAnestheticsNeurotransmitter AgentsPregnanolone3α-HSD5α-reduced steroids5α-reductaseallopregnanolone (3α,5α-THP)brexanolonefast-acting antidepressantGABAA receptorpostpartum depression

Identifiers

PMID32477260
PMCPMC7240001

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.